baber/WOPTO huggingface dataset:
Patent DE-69600420-D1 (DE)
Inventor: LOEHRKE JOHN M
IPC: B67D3/00
Filed: 1996-01-31
Granted: 1998-08-20
Abstract: A separate spout (18) is attached to each open bottle (14) in a tavern with each spout (18) having a magnetically operable valve (44) to control the flow of liquor from the bottle. To pour liquor from a bottle, an actuator (22) is placed over the spout (18). An interrogator (90) coupled to an interrogator coil (58) in the actuator (22) for sending an activation signal to a transponder (52) in the spout to read a unique spout identification code. A memory (71) provides a group of storage locations for each spout with each group storing an identification code and data regarding a total volume dispensed from the bottle (14) to which the particular spout (18) is attached, a quantity present in the particular bottle when full, and a price per volume unit. A controller (26) energizes a valve operating coil (60) in the actuator (22) to open a valve (44) in response to the interrogator (90) reading the spout identification code. Then, the controller (26) accesses the memory (71) and updates data in for the identified spout (18). The system (6) accounts for the amount of liquor dispensed from each bottle (14) and the value of that liquor to monitor the liquor inventory and sales. <IMAGE>
Patent DE-69600642-D1 (DE)
Inventor: ANDREAUS MARIO
IPC: B41F23/00
Filed: 1996-02-07
Granted: 1998-10-22
Abstract: The sheet (3) carrying a matrix array of imprints partially surrounds a rotating cylinder (4). A marker (2) is fixed to the moving member of a linear motor (1) and directed at the passing sheet. The imprints are checked by a detector (5) which verifies that any defect has been marked recognisably for purposes of subsequent processing. The marking is started by a signal to the motor to bring the marker to bear upon the sheet, and terminated by a signal for its retraction.
Patent DE-69603091-D1 (DE)
Inventor: RICHARD FRANCOIS-NO L
IPC: B22D41/56
Filed: 1996-12-18
Granted: 1999-08-05
Abstract: PCT No. PCT/EP96/05685 Sec. 371 Date Dec. 14, 1998 Sec. 102(e) Date Dec. 14, 1998 PCT Filed Dec. 18, 1996 PCT Pub. No. WO97/24201 PCT Pub. Date Jul. 10, 1997Plate change drawer for a metallurgical vessel such as a continuous casting distributor (2). The drawer has a chassis (12) mounted under the metallurgical vessel, at least one fixed upper plate (18) and at least one replaceable lower plate (22), means of applying pressure to force the lower plate (22) against the fixed plate, the chassis (12) having guide means for receiving a lower replacement plate (22) alongside the lower plate (22) during pouring, and actuation means for bringing the lower replacement plate (22) in place of the plate during pouring. The upper fixed plate (18) and the lower replaceable plate (22) have identical polygonal peripheries and are offset angularly so that they do not overlap completely. The polygonal periphery of the plate is a square or a square with rounded corners.
Patent DE-69604197-D1 (DE)
Inventor: ROBINSON RUSSELL
IPC: B62B1/20
Filed: 1996-11-19
Granted: 1999-10-14
Abstract: A bicycle towable collapsible cart comprises a framework engageable to a rear bike wheel hub and expandable to stretch a fabric basket into container form. The framework engages removable wheels and, when the cart is in its collapsed state, a small package for storage or transport is formed.
Patent DE-69606029-D1 (DE)
Inventor: MORTON S
IPC: G06V30/10
Filed: 1996-04-09
Granted: 2000-02-10
Abstract: Fiduciary mark detection system usable with an over-the-belt optical character recognition (OCR) reader for ascertaining the position and orientation of text within the destination address on parcels moving along a conveyor, comprising charged coupled device (CCD) array, analog-to-digital (A/D) converter, general purpose computer, and software program. Image processing software program comprising projection histograms, convolution filtering, correlation, radial variance, first moments of inertia, edge image analysis, Hough method, detection confidence testing. Orientation defining mark comprising fluorescent ink placed approximately in the center of the destination address block on a parcel is non obstructive of the underlying text and may be affixed to parcel any time prior to scanning. Fiduciary mark comprising two circles of different diameter oriented such that a vector from the center of large circle to center of small circle is oriented in the same direction as underlying text.
Patent DE-69613331-D1 (DE)
Inventor: MARCHESIN BRUNO
IPC: A43B5/16
Filed: 1996-12-09
Granted: 2001-07-19
Abstract: A roller skate comprising a quarter (3) articulated to a shell (5) that is in turn associated with a frame supporting a plurality of wheels (8), a support (14) for a brake (15) being connected to said frame in a rearward region, said brake interacting selectively with a braking surface upon a backward rotation imparted to said quarter (3), said roller skate comprising a guide means (17) associated with a flexible actuator means (11) such as a cable, said actuator means (11) being connected to said quarter (3) and to said support (14) so that, when said quarter (3) is rotated backwards with respect to the shell (5), a compressive thrust is produced on said flexible actuator means (11) which, by sliding along said guide means (17), moves said brake (15) into contact with said braking surface. <IMAGE>
Patent DE-69615548-D1 (DE)
Inventor: MORIYA MITSUROU
IPC: G11B7/005
Filed: 1996-04-01
Granted: 2001-10-31
Abstract: An optical record carrier and methods and apparatuses for recording and reproducing an information on and from said optical recording carrier, whereby the effects of crosstalk from adjacent tracks is reduced, and stable tracing control is possible, is achieved. A recording track to which information divided into sector units is recorded is formed in a spiral or concentric pattern on the surface of the optical record carrier. Each sector further comprises sixty frames. Each frame comprises a re-sync pattern, frame address, data, and postamble fields. Identification information identifying the sector location of the information is recorded to the data block of the first frame. The user data is recorded after the data is scrambled using a value generated by a fifteen-stage maximum-length sequence generator based on the value of this identification information. The correlation between signals on adjacent tracks is thus reduced, and the effects of crosstalk are randomized, thus reducing the effect on the track error signal and enabling extremely stable tracking control.
Patent DE-69623874-D1 (DE)
Inventor: WELLS JONATHAN PAUL
IPC: C09K3/16
Filed: 1996-07-03
Granted: 2002-10-31
Abstract: An optical fibre assembly is described exhibiting antistatic behaviour comprising at least one optical fibre and having an external organic polymer-based coating which contains a non-aqueous, or substantially non-aqueous, antistatic composition comprising (a) an antistatic agent(s), and (b) an organic liquid(s) having a dielectric constant of ≥ 15 and a boiling point of ≥ 100 DEG C.   There is also described a duct of an optical fibre transmission line for carrying an optical fibre assembly and having an inner region which defines a tubular pathway for the optical fibre assembly, wherein the duct exhibits antistatic behaviour and has incorporated into at least the inner region thereof an antistatic composition as defined above.
Patent DE-69633566-D1 (DE)
Inventor: WEHRMANN FELIX
IPC: A61K38/20
Filed: 1996-07-18
Granted: 2004-11-11
Abstract: Compositions and methods are described for the induction of apoptosis inhibition of DNA synthesis, and/or inhibiting COX-2 activity using an effective amount of salts of aminoimidazole carboxamide, 5 amino 1,2,3-triazoles or a combination of salts thereof.
Patent DE-69633718-D1 (DE)
Inventor: WARTENBERG F
IPC: H01C7/02
Filed: 1996-03-15
Granted: 2004-12-02
Abstract: A conductive polymer composition which has a resistivity at 20 DEG  C. of at most 1.0 ohm-cm and a PTC anomaly of at least 104 contains at most 64% by volume of a crystalline polymeric component and at least 36% by volume of a particulate conductive filler. A preferred conductive filler is carbon black having a DBP number of 60 to 120 cm3/100 g. Compositions of the invention, as well as other conductive polymer compositions are preferably prepared by a method in which the polymeric component and the filler are blended in a first step at a temperature greater than the melting temperature of the polymer, the mixture is then cooled, and the mixture is then mixed in a second step. The resulting composition has a PTC anomaly that is at least 1.2 times the PTC anomaly of the first mixture.
Patent DE-69635231-D1 (DE)
Inventor: BISCHOFBERGER NORBERT W
IPC: A61K31/13
Filed: 1996-02-26
Granted: 2006-02-09
Abstract: Novel compounds are described. The compounds generally comprise an acidic group, a basic group, a substituted amino or N-acyl and a group having an optionally hydroxylated alkane moiety. Pharmaceutical compositions comprising the inhibitors of the invention are also described. Methods of inhibiting neuraminidase in samples suspected of containing neuraminidase are also described. Antigenic materials, polymers, antibodies, conjugates of the compounds of the invention with labels, and assay methods for detecting neuraminidase activity are also described.
Patent DE-69703250-D1 (DE)
Inventor: DI GIUSEPPANTONIO VINCENZO
IPC: C03B9/31
Filed: 1997-11-14
Granted: 2000-11-09
Abstract: The invention falls within the sector of methods for the manufacture of glass containers. An automatic method for obtaining air bubble inclusions inside a mass of glass comprises the stages of forming a semi-finished product provided with a concavity (9) on the external surface of its bottom, having a plurality of cavities (12) with a predetermined shape and arrangement. The concavity (9) is then filled with a fluid gob of glass (8) which does not fill the cavities (12) so that decorative bubbles are formed in them.
Patent DE-69708985-D1 (DE)
Inventor: DE BIE ERIK
IPC: D06N3/12
Filed: 1997-07-09
Granted: 2002-01-24
Abstract: The invention relates to a cloth structure and has for its object to provide a cloth structure which is watertight, windtight, flame-retardant, resistant to chemicals, antistatic and permeable for water vapour. In respect of the above the invention generally provides a cloth structure, comprising:     a base cloth (4); at least one fire-retardant and flame-extinguishing first cover layer (6); and   at least one second cover layer containing polyurethane (5), which cloth structure is watertight, resistant to chemicals, at least slightly porous and thus permeable for water vapour.   <IMAGE>
Patent DE-69711292-D1 (DE)
Inventor: BORDIGNON GIUSEPPE
IPC: B21B1/46
Filed: 1997-07-17
Granted: 2002-05-02
Abstract: Method to manage an insulated cooling bed placed downstream of at least one continuous casting machine with one or more feeder ways (12a, 12b, 12c, 12d) and upstream of an outlet rollerway (20) associated with a reheating and temperature-equalisation furnace (15) serving a rolling mill (16), the cooling bed (11) comprising at the inlet a first bridge crane transfer (21a) to load the billets (13) from the feeder ways (12a, 12b, 12c, 12d) and cooperating at the outlet with a bench (14) to collect the billets (13), wherein the first bridge crane transfer (21a) removes the billets (13) from one rollerway (12) or the other and lays them gradually onto the cooling bed (11) insulated at least at the lower part, a second bridge crane transfer (21b) removes the billets (13) from one or another rollerway (12) or from the cooling bed (11) and lays the billets (13) on the outlet rollerway (20) or on the collection bench (14), the billets (13) being made to advance on the cooling bed (11) rotating on their axis. Cooling bed placed between at least a continuous casting machine and a rolling mill (16), including upstream one or more feeder rollerways (12) and downstream an outlet rollerway (20) associated with a bench (14) to collect cold billets and with a reheating and temperature-equalisation furnace (15), the bed comprising positioning seatings (19) for the billets (13) and a first bridge crane transfer (21a), the cooling bed (11) including at least at the lower part an insulated containing structure (18) and comprising a second bridge crane transfer (21b) which is driven autonomously and independently in relation to the first bridge crane transfer (21a), the second bridge crane transfer (21b) being functionally associated at least with the feeder rollerways (12), the positioning seatings (19) for the billets (13) and the outlet rollerway (20). <IMAGE>
Patent DE-69715602-D1 (DE)
Inventor: EK CARL-GUSTAF
IPC: F16L11/04
Filed: 1997-02-24
Granted: 2002-10-24
Abstract: Multilayered plastic pipe of at least two layers of different plastic material consists of polyolefin plastic having resistance to rapid crack propagation expressed as the critical temperature of the pipe. The critical temperature of the pipe is lower than weighted average of the critical temperature of the single-layer pipes of the individual plastic material, differing by at least 5 deg  C. A crack initiated in the pipe propagates a distance of at most 4 times the diameter of the pipe at a pressure difference of 0.5 MPa between inside and outside of the pipe.
Patent DE-69716823-D1 (DE)
Inventor: KLIMKOWSKI VALENTINE JOSEPH
IPC: C07D217/26
Filed: 1997-06-25
Granted: 2002-12-12
Abstract: This invention relates to a compound of the Formula I X-C(O)-Y-G-R (wherein X, Y, G and R have the values defined in the description), or a pharmaceutically acceptable salt thereof, processes and intermediates for the preparation of such a compound or salt, pharmaceutical compositions comprising such a compound or salt and methods of their use as thrombin inhibitors, coagulation inhibitors and agents for the treatment of thromboembolic disorders.
Patent DE-69717613-D1 (DE)
Title: 2'-geschützter 3'-dimethylamin, 9-etheroxim erythromycin a derivate
Inventor: YANG CHENGXI
IPC: C07H17/08
Filed: 1997-02-06
Granted: 2003-01-16
Abstract: A process of preparing a 6-O-methyl erythromycin A derivative using a 2'-protected, 9-etheroxime erythromycin A intermediate is provided. A preferred protecting group for the 2'-position is acetyl. 2'-protected, 9-etheroxime erythromycin A derivatives are also provided. Also disclosed is a method for inhibiting quaternary salt formation at the 3' amine without the need for 3'N-protecting groups.
Patent DE-69721542-D1 (DE)
Inventor: MENDELSON H
IPC: G01N33/487
Filed: 1997-06-13
Granted: 2003-06-05
Abstract: In the method of the invention, in vitro proton MRS is employed to determine the measurable ethanol concentrations in ethanol-treated erythrocyte samples of occasional and heavy drinkers. An erythrocyte to plasma ethanol concentration ratio is determined based upon the MRS measured erythrocyte concentration. Erythrocyte to plasma ethanol concentration ratios are significantly greater for heavy drinkers (a subset of alcohol tolerant individuals) as compared to the ratios calculated for occasional drinkers (non-tolerant individuals) when erythrocyte ethanol concentration is determined by MRS. Thus, the method of the present invention discriminates between alcohol tolerant individuals and alcohol non-tolerant individuals based upon the magnitude of the erythrocyte to plasma ethanol concentration ratio obtained according to the methods disclosed herein.
Patent DE-69733539-D1 (DE)
Inventor: TOTH SANDOR
IPC: A61K45/06
Filed: 1997-07-03
Granted: 2005-07-21
Abstract: PCT No. PCT/HU97/00035 Sec. 371 Date Jun. 16, 1998 Sec. 102(e) Date Jun. 16, 1998 PCT Filed Jul. 3, 1997 PCT Pub. No. WO98/04280 PCT Pub. Date Feb. 5, 1998A medically beneficial preparation is provided which contains amino acids and is applicable for augmenting the anti-viral and anti-inflammatory effects of interferon and thimidine-analogous antiherpetic drugs, for amelioration of psoriatic symptoms, and for treating Herpes virus infections.
Patent DE-69820069-D1 (DE)
Inventor: ZEMBOWER E
IPC: C07F5/04
Filed: 1998-08-21
Granted: 2004-01-08
Abstract: Robustaflavone, intermediates and analogues thereof and a method for synthesizing the same are provided. The method involves constructing apigenin ethers containing functionalities at the 6- and 3'-positions which could be cross-coupled using transition metal catalysis. The method also involves development of a regioselective iodination of an apigenin derivative at the 6-position, formation of an apigenin 3'-boronate using a palladium-catalyzed exchange of the corresponding 3'-iodide with a diboron reagent. Finally, Suzuki coupling to form the sterically congested 6-3''' biaryl bond of robustaflavone provides access to the desired biflavanoid system. Robustaflavone intermediates and analogues may be used to prepare analogues of other biflavanoids such as hinokifavone, rhusflavone and succedaneaflavone.
Patent DE-69824834-D1 (DE)
Inventor: MEERPOEL LIEVEN
IPC: A61K31/496
Filed: 1998-02-03
Granted: 2004-08-05
Abstract: The present invention concerns novel compounds of formulathe N-oxide forms, the pharmaceutically acceptable addition salts thereof and stereochemically isomeric forms thereof, wherein -A-B- forms a bivalent radical of formula -N=CH- (a), -CH=N- (b), -CH=CH- (c), L represents the acyl moiety of an amino acid; D is an azole containing 1,3- or 1,4-dioxolane derivative as broad-spectrum antifungals; their preparation, compositions containing them and their use as a medicine.
Patent DE-69837602-D1 (DE)
Inventor: HEDLEY MARY LYNNE
IPC: C12N15/87
Filed: 1998-01-22
Granted: 2007-05-31
Abstract: Disclosed is a preparation of microparticles made up of a polymeric matrix and a nucleic acid expression vector. The polymeric matrix includes one or more synthetic polymers having a solubility in water of less than about 1 mg/1. At least 90% of the microparticles have a diameter less than about 100 microns. The nucleic acid is either RNA, at least 50% of which is in the form of closed circles, or circular DNA plasmid molecules, at least 50% of which are supercoiled.
Patent DE-69906996-D1 (DE)
Inventor: GRAY D
IPC: H03M13/00
Filed: 1999-08-12
Granted: 2003-05-22
Abstract: A digital data recording channel which uses variable rate encoding. The encoder monitors an input bit stream for sequences associated with selected readback characteristics, and inserts one or more bits where desirable to improve the characteristics of the stored bit stream.
Patent DE-69908648-D1 (DE)
Inventor: HANSEN BONDO
IPC: A61P25/00
Filed: 1999-12-15
Granted: 2003-07-10
Abstract: The present invention relates to 4H-thienoÄ3,2-eÜ-1,2,4-thiadiazine derivatives, compositions thereof and methods for preparing the compounds. The compounds are useful in the treatment of diseases of the central nervous system, the cardiovascular system, the pulmonary system, the gastrointestinal system and the endocrinological system.
Patent DE-69919708-D1 (DE)
Inventor: DANIELSSON PETER
IPC: F04C19/00
Filed: 1999-06-10
Granted: 2004-09-30
Abstract: Apparatus is disclosed for pumping a pulp suspension including a housing and an impeller including a central hub, a wheel disk surrounding the central hub, and pump blades extending radially from the central hub along the wheel disk, which includes at least one opening for discharge of an entrained gas from the pump suspension, a vacuum pump at the rear face of the impeller, and vacuum pump blades mounted for rotation within the vacuum pump housing, which includes an outer wall which is eccentrically disposed with respect to the vacuum pump blade, and a rear wall which includes a suction port for receiving the entrained gas, and with the vacuum pump housing mounted adjacent to the central hub to provide a gap therebetween, so that vacuum pump housing is axially adjustable so that the gap can be altered by axial adjustment of the vacuum pump housing.
Patent DE-69925251-D1 (DE)
Inventor: ARTMAN D
IPC: A61K31/22
Filed: 1999-03-04
Granted: 2005-06-16
Abstract: Preparations and extracts of valerian, as well as isovaleramide, isovaleric acid, and its pharmaceutically acceptable salts, esters, and substituted amides, and other valerian-related compounds, in combination with NSAIDs exhibit clinically significant pharmacological properties which implicate a treatment for acute muscular aches, strains, and sprains which occur from a localized, external insult to a particular muscle or muscle group outside of, or peripheral to, the CNS. The compositions in question generally are non-cytotoxic and do not elicit weakness or sedative activity at doses that are effective for the symptomatic treatment of such pathological conditions.
Patent DE-69930147-D1 (DE)
Inventor: MURDIN D
IPC: A61P27/02
Filed: 1999-12-02
Granted: 2006-04-27
Abstract: A host is immunized against infection by a strain of Chlamydia by initial administration of an attenuated bacteria harbouring a nucleic acid encoding a Chlamydia protein followed by administration of a Chlamydia protein in ISCOMs. This procedure enables a high level of protection to be achieved.
Patent DE-69930514-D1 (DE)
Inventor: BATTS H
IPC: A47G25/00
Filed: 1999-06-15
Granted: 2006-05-11
Abstract: A ship-on garment hanger (10) having ramp means (39, 40) on the hanger body to prevent dislodgement of a garment from the hanger by outwardly directly dislodging forces and end shields (50) on the outside edges of the clamps to prevent dislodgement of a garment from the garment hanger by inwardly directed dislodging forces, the hanger being nestable with similar hangers to maximize shipping space.
Patent DE-69936192-D1 (DE)
Inventor: GOTO MASAAKI
IPC: C07K14/435
Filed: 1999-04-09
Granted: 2007-07-12
Abstract: A novel protein and a process of producing the protein is provided. The protein is a glycoprotein having activity of suppressing the differentiation and/or maturation of adipocyte, having a molecular weight of about 45 kD under non-reducing conditions and about 28 kD and/or 23 kD under reducing conditions, and exhibiting affinity to heparin. A process of producing the protein comprising culturing human fibroblasts and purifying the culture broth by chromatography using an ion exchange column, affinity column, and reverse phase column.  A cDNA encoding the protein and a process of producing the protein using the cDNA are also provided. The protein of the present invention is useful as a pharmaceutical composition for preventing or treating obesity or as an antigen for establishing immunological diagnosis, etc..